This article was originally published in The Gray Sheet
MicroMed Technology,Inc.: Completes a $10 mil. private placement with equity/venture capital firms Oxford Ventures, Schroder Ventures and Charterhouse Group. The Woodlands, Texas-based MicroMed has tabbed the funds for ongoing preclinical testing of its DeBakey VAD ventricular assist device for use as a bridge to transplant for patients suffering from compromised ventricular blood pumping capability ("The Gray Sheet" July 7, 1997, I&W-6)...
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.